ClinicalTrials.gov
ClinicalTrials.gov Menu

Patient Satisfaction in Stroke Patients (PatZuFrie)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00994409
Recruitment Status : Completed
First Posted : October 14, 2009
Last Update Posted : December 1, 2010
Sponsor:
Collaborators:
Center for Stroke Research Berlin
German Federal Ministry of Education and Research
Information provided by:
Charite University, Berlin, Germany

Brief Summary:
The objective of this trial is to guarantee a follow-up of all stroke and transient ischemic attack (TIA) patients. With this follow-up assessment long term effects of therapy and prevention measures can be detected and monitored. It is part of quality assurance.

Condition or disease
Stroke

Detailed Description:
Primary efficacy endpoint: Number of patients who state that they received all the information they want about the causes and nature of their illness Key secondary endpoint(s): Compliance/adherence with discharge medication. Re-events. Degree of Disability. Activities of daily living. Mortality.

Study Type : Observational
Estimated Enrollment : 1200 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Berliner Schlaganfallregister - Nachbefragung Von Patienten Mit Schlaganfall
Study Start Date : July 2008
Actual Primary Completion Date : July 2010
Actual Study Completion Date : November 2010



Primary Outcome Measures :
  1. Primary efficacy endpoint: Number of patients who state that they received all the information they want about the causes and nature of their illness. [ Time Frame: September 2010 ]

Secondary Outcome Measures :
  1. Compliance/adherence with discharge medication Activities of daily living [ Time Frame: September 2010 ]
  2. Re-events [ Time Frame: September 2010 ]
  3. Degree of Disability [ Time Frame: September 2010 ]
  4. Mortality [ Time Frame: September 2010 ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Stroke and TIA patients treated at the Charite with acute stroke or TIA onset less than 7 days
Criteria

Inclusion Criteria:

  • all patients eligible

Exclusion Criteria:


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00994409


Locations
Germany
Dept. Neurology, Charité Campus Benjamin Franklin
Berlin, Germany
Sponsors and Collaborators
Charite University, Berlin, Germany
Center for Stroke Research Berlin
German Federal Ministry of Education and Research
Investigators
Principal Investigator: Peter U Heuschmann, Professor Center for Stroke Research Berlin

Additional Information:
Responsible Party: Christian H Nolte MD, Dept. Neurology, Charite Campus Benjamin Franklin
ClinicalTrials.gov Identifier: NCT00994409     History of Changes
Other Study ID Numbers: CSB-PatZuFrie
EA4/019/08
First Posted: October 14, 2009    Key Record Dates
Last Update Posted: December 1, 2010
Last Verified: November 2010

Keywords provided by Charite University, Berlin, Germany:
Stroke

Additional relevant MeSH terms:
Stroke
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Vascular Diseases
Cardiovascular Diseases